Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Armo Biosciences Inc. (ARMO)

Armo Biosciences Inc. (ARMO)
49.98 +0.01 (+0.02%) 06/21/18 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Thu, Jun 21st, 2018
Day Low
49.96
Day High
50.01
Open 49.98
Previous Close 49.97 49.97
Volume 297,400 297,400
Avg Vol 212,740 212,740
Stochastic %K 67.76% 67.76%
Weighted Alpha N/A N/A
5-Day Change -0.05 (-0.10%) -0.05 (-0.10%)
52-Week Range 25.10 - 57.19 25.10 - 57.19
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,519,892
  • Shares Outstanding, K 30,410
  • Annual Sales, $ 0 K
  • Annual Income, $ -42,430 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 9.69
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -10.59
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 07/02/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/18
See More
  • Average Estimate -0.54
  • Number of Estimates 3
  • High Estimate -0.42
  • Low Estimate -0.66
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.80 +0.36%
on 05/22/18
Period Open: 49.90
50.05 -0.14%
on 06/20/18
+0.08 (+0.16%)
since 05/21/18
3-Month
25.10 +99.12%
on 04/19/18
Period Open: 39.67
50.05 -0.14%
on 06/20/18
+10.31 (+25.99%)
since 03/21/18

Business Summary

ARMO Biosciences, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing immunotherapies for the treatment of cancer, cardiovascular disease, fibrosis and inflammation. The Company's platform molecule AM0010 is a pegylated form of recombinant human IL-10, which has immune stimulating...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 50.03
1st Resistance Point 50.01
Last Price 49.98
1st Support Level 49.96
2nd Support Level 49.93
3rd Support Level N/A

See More

52-Week High 57.19
Last Price 49.98
Fibonacci 61.8% 44.93
Fibonacci 50% 41.15
Fibonacci 38.2% 37.36
52-Week Low 25.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro